These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 28209170)
1. LincRNAFEZF1-AS1 represses p21 expression to promote gastric cancer proliferation through LSD1-Mediated H3K4me2 demethylation. Liu YW; Xia R; Lu K; Xie M; Yang F; Sun M; De W; Wang C; Ji G Mol Cancer; 2017 Feb; 16(1):39. PubMed ID: 28209170 [TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA AFAP1-AS1 predicts a poor prognosis and regulates non-small cell lung cancer cell proliferation by epigenetically repressing p21 expression. Yin D; Lu X; Su J; He X; De W; Yang J; Li W; Han L; Zhang E Mol Cancer; 2018 May; 17(1):92. PubMed ID: 29793547 [TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA HOXA-AS2 promotes gastric cancer proliferation by epigenetically silencing P21/PLK3/DDIT3 expression. Xie M; Sun M; Zhu YN; Xia R; Liu YW; Ding J; Ma HW; He XZ; Zhang ZH; Liu ZJ; Liu XH; De W Oncotarget; 2015 Oct; 6(32):33587-601. PubMed ID: 26384350 [TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA FEZF1-AS1 indicates a poor prognosis of gastric cancer and promotes tumorigenesis via activation of Wnt signaling pathway. Wu X; Zhang P; Zhu H; Li S; Chen X; Shi L Biomed Pharmacother; 2017 Dec; 96():1103-1108. PubMed ID: 29239821 [TBL] [Abstract][Full Text] [Related]
5. Upregulation of the long noncoding RNA FOXD2-AS1 promotes carcinogenesis by epigenetically silencing EphB3 through EZH2 and LSD1, and predicts poor prognosis in gastric cancer. Xu TP; Wang WY; Ma P; Shuai Y; Zhao K; Wang YF; Li W; Xia R; Chen WM; Zhang EB; Shu YQ Oncogene; 2018 Sep; 37(36):5020-5036. PubMed ID: 29789713 [TBL] [Abstract][Full Text] [Related]
6. TEAD4 modulated LncRNA MNX1-AS1 contributes to gastric cancer progression partly through suppressing BTG2 and activating BCL2. Shuai Y; Ma Z; Liu W; Yu T; Yan C; Jiang H; Tian S; Xu T; Shu Y Mol Cancer; 2020 Jan; 19(1):6. PubMed ID: 31924214 [TBL] [Abstract][Full Text] [Related]
7. Long noncoding AGAP2-AS1 is activated by SP1 and promotes cell proliferation and invasion in gastric cancer. Qi F; Liu X; Wu H; Yu X; Wei C; Huang X; Ji G; Nie F; Wang K J Hematol Oncol; 2017 Feb; 10(1):48. PubMed ID: 28209205 [TBL] [Abstract][Full Text] [Related]
8. LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC). He R; Zhang FH; Shen N Biomed Pharmacother; 2017 Nov; 95():331-338. PubMed ID: 28858731 [TBL] [Abstract][Full Text] [Related]
9. LncRNA FEZF1-AS1 Modulates Cancer Stem Cell Properties of Human Gastric Cancer Through miR-363-3p/HMGA2. Hui Y; Yang Y; Li D; Wang J; Di M; Zhang S; Wang S Cell Transplant; 2020; 29():963689720925059. PubMed ID: 32638620 [TBL] [Abstract][Full Text] [Related]
10. LncRNA SNHG6 is Associated with Poor Prognosis of Gastric Cancer and Promotes Cell Proliferation and EMT through Epigenetically Silencing p27 and Sponging miR-101-3p. Yan K; Tian J; Shi W; Xia H; Zhu Y Cell Physiol Biochem; 2017; 42(3):999-1012. PubMed ID: 28683446 [TBL] [Abstract][Full Text] [Related]
11. LncRNA SOX21-AS1 is associated with progression of hepatocellular carcinoma and predicts prognosis through epigenetically silencing p21. Wei C; Wang H; Xu F; Liu Z; Jiang R Biomed Pharmacother; 2018 Aug; 104():137-144. PubMed ID: 29772433 [TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA actin filament-associated protein 1 antisense RNA 1 promotes malignant phenotype through binding with lysine-specific demethylase 1 and repressing HMG box-containing protein 1 in non-small-cell lung cancer. Yu S; Yang D; Ye Y; Liu P; Chen Z; Lei T; Pu J; Liu L; Wang Z Cancer Sci; 2019 Jul; 110(7):2211-2225. PubMed ID: 31069893 [TBL] [Abstract][Full Text] [Related]
13. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells. Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672 [TBL] [Abstract][Full Text] [Related]
14. Long Noncoding RNA FEZF1-AS1 Promotes Proliferation and Inhibits Apoptosis in Ovarian Cancer by Activation of JAK-STAT3 Pathway. Zhao X; Cheng Z; Wang J Med Sci Monit; 2018 Nov; 24():8088-8095. PubMed ID: 30416194 [TBL] [Abstract][Full Text] [Related]
15. EGR1-Mediated Transcription of lncRNA-HNF1A-AS1 Promotes Cell-Cycle Progression in Gastric Cancer. Liu HT; Liu S; Liu L; Ma RR; Gao P Cancer Res; 2018 Oct; 78(20):5877-5890. PubMed ID: 30185552 [TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA NNT-AS1 sponges miR-424/E2F1 to promote the tumorigenesis and cell cycle progression of gastric cancer. Chen B; Zhao Q; Guan L; Lv H; Bie L; Huang J; Chen XB J Cell Mol Med; 2018 Oct; 22(10):4751-4759. PubMed ID: 30006956 [TBL] [Abstract][Full Text] [Related]
17. LncRNA-FEZF1-AS1 Promotes Tumor Proliferation and Metastasis in Colorectal Cancer by Regulating PKM2 Signaling. Bian Z; Zhang J; Li M; Feng Y; Wang X; Zhang J; Yao S; Jin G; Du J; Han W; Yin Y; Huang S; Fei B; Zou J; Huang Z Clin Cancer Res; 2018 Oct; 24(19):4808-4819. PubMed ID: 29914894 [No Abstract] [Full Text] [Related]
18. Combination LSD1 and HOTAIR-EZH2 inhibition disrupts cell cycle processes and induces apoptosis in glioblastoma cells. Zhao J; Jin W; Yi K; Wang Q; Zhou J; Tan Y; Xu C; Xiao M; Hong B; Xu F; Zhang K; Kang C Pharmacol Res; 2021 Sep; 171():105764. PubMed ID: 34246782 [TBL] [Abstract][Full Text] [Related]
19. FEZF1-AS1 is a key regulator of cell cycle, epithelial-mesenchymal transition and Wnt/β-catenin signaling in nasopharyngeal carcinoma cells. Cheng Y Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30355645 [TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA FEZF1-AS1 in human cancers. Zhou Y; Xu S; Xia H; Gao Z; Huang R; Tang E; Jiang X Clin Chim Acta; 2019 Oct; 497():20-26. PubMed ID: 31276636 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]